OxThera Company
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
Technology:
Others
Headquarters:
Stockholm, Stockholms Lan, Sweden
Funding Status:
Late Stage Venture
Founded Date:
2005
Last Funding Type:
Seed
Investors Number:
10
Estimated Revenue:
$10M to $50M
Employee Number:
11-50
Total Funding:
€4.9M
Industry:
PharmTech
Investor Type:
For Profit